Announcement PDF Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 1 / 4 Announcement Summary Entity name PARADIGM BIOPHARMACEUTICALS LIMITED.. Announcement Type New announcement Date of this announcement Thursday October 08, 2026 Details of +securities that have ceased ASX +security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation PARAAD CONVERTIBLE NOTES 1,171,477 Repayment or redemption of +convertible debt security without conversion 08/10/2026 Refer to next page for full details of the announcement Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 2 / 4 Part 1 - Announcement Details 1.1 Name of +Entity PARADIGM BIOPHARMACEUTICALS LIMITED.. We (the entity named above) provide the following information about our issued capital. 1.2 Registered Number Type ACN Registration Number 169346963 1.3 ASX issuer code PAR 1.4 The announcement is 1.5 Date of this announcement 8/10/2026 New announcement Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 3 / 4 Part 2 - Details of +equity securities or +debt securities that have ceased ASX +Security Code and Description PARAAD : CONVERTIBLE NOTES Unquoted +equity securities that have ceased Number of securities that have ceased 1,171,477 Reason for cessation Repayment or redemption of +convertible debt security without conversion Date of cessation 8/10/2026 Is the entity paying any consideration for the cessation? In what currency is the consideration being paid? USD - US Dollar Consideration amount per +security paid by the entity for the cessation USD 1.198900000000 Any other information the entity wishes to notify to ASX about the cessation? Yes Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 4 / 4 Part 3 - Issued capital following changes Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise: The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) ASX +security code and description Total number of +securities on issue PAR : ORDINARY FULLY PAID 626,433,356 PAROB : OPTION EXPIRING 01-DEC-2026 116,360,866 3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue PARAAC : PERFORMANCE RIGHTS 11,127,100 PARAR : OPTION EXPIRING 11-FEB-2028 EX $1.00 151,293 PARAAE : OPTION EXPIRING 30-JUN-2027 EX $0.65 3,000,000 PARAAD : CONVERTIBLE NOTES 3,125,708 Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.